Immuno-PET-Glioma Study, a Proof-of-principle Imaging Study

Sex: All

Ages: 18 Years – 80 Years

Healthy volunteers: 1

Phase: NA

Enrollment: 20

Sponsor: Kepler University Hospital

Summary

Imaging of proinflammatory activated microglia by P2X7 receptor scintigraphy in PET scanner in glioblastoma patients.

Eligibility Criteria

Inclusion Criteria:Patients with a new probable diagnosis of glioblastoma based on MRI imaging.prior to initiation of specific tumor therapy and prior to any surgery (including biopsy)short-term medication for cerebral edema (including corticosteroids) and short-term administration of antiepileptic drugs are not a reason for exclusionExclusion Criteria:Non-business capacityPregnancybreastfeeding periodOther malignant disease (active)Concurrent participation in another clinical trialForeseeable compliance problems

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05753995). StuddyBuddy aggregates publicly available trial information.